Novel Thulium Fiber Laser for Enucleation of Prostate: A Retrospective Comparison with Open Simple Prostatectomy.


Journal

Journal of endourology
ISSN: 1557-900X
Titre abrégé: J Endourol
Pays: United States
ID NLM: 8807503

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 30 11 2018
medline: 12 2 2020
entrez: 30 11 2018
Statut: ppublish

Résumé

The objective of this study was to assess the efficacy and safety of novel thulium fiber laser enucleation of the prostate (ThuFLEP) vs conventional open simple retropubic prostatectomy (OP) for large volume benign prostatic hyperplasia (BPH). We performed a retrospective review of patients who underwent surgical treatment for large volume BPH (>80 cc) from 2015 to 2017. Preoperative patient examination included the assessment of functional parameters: International Prostate Symptom Score (IPSS), quality of life (QoL), maximum urine flow rate (Q A total of 130 patients were included in the study. Of these, 40 patients underwent OP, and 90 patients underwent ThuFLEP. Groups were similar in terms of preoperative functional parameters (IPSS, QoL, and Q Despite the equally high efficacy of both modalities for infravesical obstruction due to BPH, ThuFLEP is a minimally invasive modality that is associated with a shorter hospital stay, a significantly greater return to normal activities, and a considerable reduction in rehabilitation time. Our results demonstrated that the ThuFLEP is a highly efficacious, minimally invasive modality for the management of BPH in large volume glands (>80 cc).

Identifiants

pubmed: 30489154
doi: 10.1089/end.2018.0791
doi:

Substances chimiques

Thulium 8RKC5ATI4P

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-21

Auteurs

Dmitry Enikeev (D)

1 Institute of Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Zhamshid Okhunov (Z)

2 Department of Urology, University of California, Irvine, California.

Leonid Rapoport (L)

1 Institute of Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Mark Taratkin (M)

1 Institute of Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Mikhail Enikeev (M)

1 Institute of Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Olesya Snurnitsyna (O)

1 Institute of Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Taylor Capretz (T)

2 Department of Urology, University of California, Irvine, California.

Jasur Inoyatov (J)

1 Institute of Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Petr Glybochko (P)

1 Institute of Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH